Firas Abdollah | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Firas Abdollah | Medicine and Dentistry | Best Researcher Award

Dr Firas Abdollah,Henry Ford Health,United States

Dr. Firas Abdollah is a Clinical Associate Professor and Vice-Chair of Academic and Research at the Vattikuti Urology Institute, Henry Ford Hospital. With dual citizenship in the USA and Italy, he has a distinguished career in urologic oncology and robotic surgery. He specializes in the epidemiology of urologic cancers and the development of predictive tools for cancer outcomes. He has held research and faculty positions at leading institutions, including Wayne State University and Michigan State University. His extensive contributions to urology have earned him numerous awards, and his research has been published in top-tier journals. Dr. Abdollah is also a medical consultant for Intuitive Surgical Inc.

Publication Profile

Orcid

Education

Dr Firas Abdollah began his academic journey at Al Mutamayizeen Secondary School in Baghdad, Iraq, where he completed his Bachelor of Science between 1995 and 1997. He then pursued a Doctor of Medicine degree at the College of Medicine, Baghdad University, graduating in 2003. Following his medical education, he underwent extensive training through internships and residency at San-Raffaele Hospital, University Vita-Salute, in Milan, Italy, from 2004 to 2012. Further advancing his expertise, he completed a prestigious Fellowship in Robotic Urologic Oncology at the Henry Ford Hospital, Vattikuti Urology Institute, in Detroit, Michigan, USA, from 2015 to 2018.

Experience

Associate Professor at Wayne State University, a position he has held since 2020, and also serves as Vice-Chair of Academic and Research at the Vattikuti Urology Institute, Henry Ford Hospital. In addition, he has been a Clinical Associate Professor at Michigan State University since 2022. His extensive experience in medical consulting includes his current role at Intuitive Surgical Inc., California, starting in 2024. Previously, he was a Medical Consultant for the Department of Urology at the Academic Hospital San Raffaele in Milan, Italy, from 2011 to 2013, and served as a Medical Consultant and Advisor for GenomeDx Biosciences in Vancouver, Canada, from 2014 to 2020. His collaboration with KOELIS Inc. in Delaware lasted from 2022 to 2024 through a consulting and research agreement. Dr. [Name] has also been actively involved in research, having worked as a Research Investigator at Henry Ford Hospital, focusing on prognostic models for prostate and bladder cancers from 2014 to 2015. Earlier in his career, he contributed to cancer prognostics and health outcomes research at the University of Montreal in 2010.

Awards & Honors

  • Best Poster Award – Società Italiana di Urologia Annual Congress (2007)
  • Best of AUA/JUA Meeting Award – AUA Annual Meeting, Washington DC (2011)
  • Best Paper – European Urology Resident Corner (2012)
  • Best Poster Award – European Association of Urology Congress (2012, 2013, 2014, 2018)
  • Excellence in Research Award – Southeast Michigan Center for Medical Education (2017)
  • Top 1% in Field for Peer Reviews – Publons (2017)
  • First Place, Fellow Clinical Research – European Association of Urology Congress (2018)

 

Research Focus

  • Epidemiology of Urologic-Oncology Diseases
  • Prostate, Kidney, Bladder, Testicular, and Penile Cancers
  • Development of Prediction Tools for Disease-Specific Mortality and Recurrence
  • Robotic Urologic Oncology and Outcomes Resear

 

Publication
  • 📖 The importance of pelvic lymph node dissection in the elderly: Implications for interpretation of NCCN guidelines
  • 📖 A novel tool for predicting urinary incontinence after radical prostatectomy
  • 📖 Competing risks analysis of long-term survival in node-positive prostate cancer
  • 📖 Predicting pathological outcomes in patients undergoing robot-assisted radical prostatectomy
  • 📖 Testing the impact of adjuvant radiotherapy on overall mortality in prostate cancer patients
  • 📖 External validity of EORTC 30904 in North American patients with renal cell carcinoma

Omnia Ahmed | Medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Omnia Ahmed | Medicine | Best Researcher Award

Dr. Omnia Ahmed, Nanotoxicology Project lab, Japan

Dr. Omnia H.M. Ahmed is a researcher in the field of nanotoxicology, currently working at the Nanotoxicology Project Lab in Japan. Her expertise lies in the study of various poisonous substances and drugs, focusing on their classification, mechanisms of action, clinical toxicity features, diagnosis, and management. She applies medical science principles to forensic toxicology and specializes in dependence-producing substances. Dr. Ahmed collaborates in laboratory experiments, addressing challenges in analytical toxicology, and investigates newly emerging hazardous materials, including carbon nanotubes.

Education:

Dr. Omnia Ahmed holds a Master of Medical Science in Forensic Medicine and Clinical Toxicology from the Faculty of Medicine, Aswan University, Egypt, which she completed in March 2019. She earned her M.B.B.CH degree with honors from the Faculty of Medicine and Surgery, Sohag University, Egypt, in November 2012, achieving an excellent cumulative grade of 85.02%.She is currently engaged in the Nanotoxicology Project Lab in Japan, focusing on research in nanotoxicology, forensic medicine, and clinical toxicology.

Professional Profiles:

Google Scholar

ORCID Profile

Professional Experience:

Nanotoxicology Project Lab, Japan (April 2013 – March 2014)

Conducted research on nanotoxicology, focusing on the impact of nanomaterials on biological systems.

Trainee Course (Full-time Employee), University Hospital, Faculty of Medicine and Surgery, Sohag University, Egypt (April 2014 – March 2015)

Completed a comprehensive training program in various medical disciplines, gaining hands-on clinical experience.

General Practitioner, Ministry of Health, Egypt (April 2015 – June 2015)

Provided primary healthcare services, diagnosing and treating a variety of medical conditions.

Physician, Internal Medicine and Clinical Toxicology Department, Edfu General Hospital, Aswan City, Egypt (July 2015 – April 2019)

Managed cases related to internal medicine and clinical toxicology, including poisoning and toxin exposure treatments.

Demonstrator & Research Associate, Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Aswan University, Egypt (April 2019 – Present)

Assisted in teaching forensic medicine and clinical toxicology to medical students.

Assistant Professor, Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Aswan University, Egypt (April 2019 – Present)

Led courses in forensic medicine, clinical toxicology, and medico-legal studies.

Researcher, Nano-Toxicology Lab Project, Experimental Pathology and Tumor Biology Department, School of Medical Science, Nagoya City University, Japan (October 2022 – Present)

Conducting advanced research on nanotoxicology, studying the effects of nanoparticles on human health.

Ph.D. Student, Nano-Toxicology Lab Project, Experimental Pathology and Tumor Biology Department, School of Medical Science, Nagoya City University, Japan (October 2022 – Present)

Pursuing doctoral research in nanotoxicology, focusing on nanoparticle interactions with biological systems.

Research Interests:

Nanotoxicology: Investigating the toxic effects of nanomaterials, particularly carbon nanotubes, on human health and the environment.

Analytical Toxicology: Developing methods for detecting and analyzing poisonous substances and drugs.

Forensic Toxicology: Applying medical sciences to legal investigations involving toxic substances.

Drug Toxicity and Dependence: Studying the mechanisms, clinical features, and management of toxic and dependence-producing substances.

Toxicokinetics and Toxicodynamics: Understanding how toxic substances interact with biological systems.

Emerging Toxicants: Assessing newly introduced hazardous substances and their potential risks.

Team-Based Laboratory Research: Conducting collaborative experiments to address challenges in toxicology.

 Awards And Honors :

Dr. Omnia Ahmed has achieved significant academic milestones, including an Excellent degree with Class Honors in M.B.B.CH from Sohag Faculty of Medicine, Sohag University in 2012, and a Very Good Degree in M.SC. Forensic Medicine and Clinical Toxicology from Aswan Faculty of Medicine, Aswan University in 2019. She is currently a recipient of the MEXT Scholarship in Japan, spanning from April 2022 to October 2026.

Top Notable Publications:

A Review of the Carcinogenic Potential of Thick Rigid and Thin Flexible Multi-Walled Carbon Nanotubes in the Lung

Authors: Omnia Hosny Mohamed Ahmed, Aya Naiki-Ito, Satoru Takahashi, William T. Alexander, et al.

Journal: Nanomaterials

Volume: 15(3), Article 168

Year: 2025

Fullerene and Fullerene Whisker are Not Carcinogenic to the Lungs and Pleura in Rat Long-Term Study After 2-Week Intra-Tracheal Intrapulmonary Administration

Authors: AN Sheema, A Naiki-Ito, A Kakehashi, OHM Ahmed, DB Alexander, et al.

Journal: Archives of Toxicology

Volume: 98(12), Pages 4143-4158

Year: 2024

Assessment of Pulmonary Toxicity and Carcinogenicity of Carbon Nano-Horns (CNH) and Carbon Nano-Brushes (CNB) Using Intra Tracheal Instillation in Rats

Authors: OHM Ahmed, DM Saleh, DB Alexander, WT Alexander, et al.

Conference: The 51st Annual Meeting of the Japanese Society of Toxicology

Year: 2024

Carcinogenicity Risk Assessment of Various Carbon Nanotubes by Intra-Tracheal Intra-Pulmonary Spray (TIPS) Dosing Followed by 2-Year Observation

Authors: H Tsuda, O Ahmed, D Saleh, W Alexander, D Alexander, T Numano, et al.

Journal: Annals of Work Exposures and Health

Volume: 67 (Supplement_1), Pages i43-i44

Year: 2023

SOC-III-01 The Toxic and Carcinogenic Potential of Three Different Sizes of Double-Walled Carbon Nanotubes in the Rat Lung After Intratracheal Instillation

Authors: DM Saleh, WT Alexander, DB Alexander, M Abdelgaied, AM El-Gazzar, OHM Ahmed, et al.

Journal: Toxicology Letters

Volume: 368, Pages S42-S43

Year: 2022

Assessment of the Toxicity and Carcinogenicity of Double-Walled Carbon Nanotubes in the Rat Lung After Intratracheal Instillation: A Two-Year Study

Authors: DM Saleh, S Luo, OHM Ahmed, DB Alexander, WT Alexander, et al.

Journal: Particle and Fibre Toxicology

Volume: 19(1), Article 30

Year: 2022

Comparative Toxicity and Carcinogenicity Pulmonary Study of Double-Walled Carbon Nanotubes (DWCNT) with Multi-Walled Carbon Nanotubes-7 (MWCNTs-7) in a Rat Model

Authors: DM Saleh, S Luo, DB Alexander, AM El-Gazzar, M Abdelgaied, OHM Ahmed, et al.

Conference: The 48th Annual Meeting of the Japanese Society of Toxicology

Poster: P-33E

Year: 2021

Comparative Carcinogenicity Study of a Thick, Straight-Type and a Thin, Tangled-Type Multi-Walled Carbon Nanotube Administered by Intra-Tracheal Instillation in the Rat

Authors: DM Saleh, WT Alexander, T Numano, OHM Ahmed, S Gunasekaran, et al.

Journal: Particle and Fibre Toxicology

Volume: 17, Pages 1-14

Citations: 38

Year: 2020

Evaluation of Poisoning Patterns in Aswan Governorate in the Period from 1st of June 2017 to 31st of December 2017 (Prospective Study)

Authors: OH Mohamed, SM George, HA Yassa

Journal: Zagazig Journal of Forensic Medicine

Volume: 17(2), Pages 84-95

Citations: 3

Year: 2019

Conclusion:

Dr. Omnia Ahmed is a strong contender for the Best Researcher Award given her expertise in nanotoxicology, research impact, and global collaborations. Strengthening her application with clear metrics of impact, leadership roles, and interdisciplinary influence would further solidify her case.